Nishadil
Signup Signin
Delhi | 25°C (windy)
The Watchdogs Are Barking: Why Metsera's Big Deal Just Hit a Snag

The Watchdogs Are Barking: Why Metsera's Big Deal Just Hit a Snag
Wall Street's Relentless Climb: Unpacking the Forces Behind the Market's Ascent

Wall Street's Relentless Climb: Unpacking the Forces Behind the Market's Ascent
The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle

The Billion-Dollar Standoff: Pfizer Unleashes on Novo Nordisk in Metsera Bid Battle
The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?
Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s

Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s
Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid

Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid
Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market

Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market
Load more..